Two ISCRM Trainees Named to 2021 Husky 100 List

June 14, 2021 | Categories: Award | Tagged: , , , , , ,

ISCRM trainees Eric Scott Nealy, PhD and Kendan Jones-Isaac have been recognized for their contributions to cancer and kidney research. Read More

Julie Mathieu

New Investigator Award for Julie Mathieu Funds Collaborative Cancer Research

June 11, 2021 | Categories: Award, Research | Tagged: , , , ,

Fueled in part by a New Investigator Award from the Cancer Consortium, ISCRM faculty member Julie Mathieu, PhD is partnering with scientists at the Institute for Protein Design and Fred Hutch to develop new treatments for renal cell carcinoma. Read More

Supercharging Antibodies for Better Medicine

April 2, 2021 | Categories: Uncategorized | Tagged: , , , ,

Researchers from the Ruohola-Baker Lab have collaborated with the Institute for Protein Design on a technology in which designed proteins assemble antibodies in nanocage structures, increasing their potency against cancer, COVID-19, and other diseases. Read More

Research from Doulatov Lab in the Journal Blood Offers Stem Cell-Aided Insights on MDS Onset

June 13, 2019 | Categories: Research | Tagged: , ,

Myelodysplastic syndromes (MDS) are heterogenous blood disorders that affect up to 170,000 people in the United States, primarily over the age of 60. While early symptoms, including anemia (characterized by fatigue), are not serious, MDS is a high-risk factor for leukemia. Currently there are few treatment for MDS and the causes remain poorly understood. Read More

Studying Cell Signaling in the Prostate

April 15, 2019 | Categories: Core Faculty, Research | Tagged: , , ,

While prostate cancer may not be as deadly as other cancers – five-year survival rates can exceed 90%, especially if the disease is localized – incidence rates overall are increasing. For 2019 alone, The American Cancer Society predicts the United States will see roughly 175,000 new cases and 32,000 deaths associated with prostate cancer. Read More

Illustration of approach to ITOMIC study of cancer patients.

Study tells of cancer patient’s unprecedented level of care

January 25, 2016 | Categories: Research | Tagged: , , ,

32 researchers at 14 institutions joined to identify personalized treatment options for woman with metastatic triple-negative breast cancer A new report documents one cancer patient’s experience with an unprecedented level of individualized care, provided through the University of Washington Center for Cancer Innovation. In the study, 32 experts from 14 institutions teamed to identify potential interventions for a patient […] Read More